Clinical trials for both Ozempic and Wegovy demonstrated consistent weight loss outcomes without site-dependent variations
In December 2014, the Food and Drug Administration (FDA) approved liraglutide for weight loss, and semaglutide was approved for diabetes in 2017 and obesity in 2021, opening a new era of obesity treatment
Lunch: A colorful salad is an excellent midday meal
In a single piece, he concisely captures: the state of the field the most important clinical trials where the pipeline is headed These Clinical trials are raising the bar and expanding future treatment options: Retatrutide ~24% weight loss (triple agonist) MariTide 1216% weight loss (GLP-1 + GIP antagonist) CagriSema up to 20% weight loss + ~2% HbA1c drop Orforglipron oral GLP-1, HbA1c 1.5%, weight 7.6% IcoSema weekly semaglutide + once-weekly insulin Even more exciting
Yes, semaglutide from Hers is legitimate, but with an important caveat
A study showed that 12-week treatment with cinnamon (500 mg/day) decreased the percentage of fat mass and increased lean mass, improving overall body composition
